Jyothy Labs Limited carries a market capitalization of 73.44B, placing it among publicly traded companies globally. Its enterprise value stands at 103.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 73.44B |
| Enterprise Value | 103.68B |
Jyothy Labs Limited trades at a trailing price-to-earnings ratio of 30.32.
| PE Ratio | 30.32 |
| PS Ratio | 3.59 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Jyothy Labs Limited trades at an EV/EBITDA multiple of 25.37 and an EV/FCF ratio of 2,583.22. The EV/Sales ratio of 3.59 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 25.37 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.59 |
| EV / EBITDA | 25.37 |
| EV / EBIT | 25.37 |
| EV / FCF | 2,583.22 |
Jyothy Labs Limited maintains a current ratio of 5.56, meaning it holds 5.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.73, indicating elevated leverage, while an interest coverage ratio of 75.27 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.56 |
| Quick Ratio | 2.95 |
| Debt / Equity | 6.73 |
| Debt / EBITDA | N/A |
| Interest Coverage | 75.27 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 404.29 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Jyothy Labs Limited has paid 1.21B in income taxes, reflecting an effective tax rate of 26.08.
| Income Tax | 1.21B |
| Effective Tax Rate | 26.08 |
Jyothy Labs Limited's stock has declined approximately -41.78431% over the past 52 weeks. The 50-day moving average sits at 226.35, while the 200-day moving average is 273.76.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.78431% |
| 50-Day Moving Average | 226.35 |
| 200-Day Moving Average | 273.76 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Jyothy Labs Limited generated 28.92B in revenue and converted that into 3.42B in net income, yielding earnings per share of 9.32. EBITDA reached 4.09B, while operating income came in at 4.09B.
| Revenue | 28.92B |
| Gross Profit | 13.69B |
| Operating Income | 4.09B |
| Pretax Income | 4.63B |
| Net Income | 3.42B |
| EBITDA | 4.09B |
| EBIT | 4.09B |
| Earnings Per Share (EPS) | 9.32 |
Jyothy Labs Limited operates with a gross margin of 47.33, reflecting its pricing power and cost economics. The operating margin of 14.13 and net profit margin of 11.82 provide insight into operational efficiency.
| Gross Margin | 47.33 |
| Operating Margin | 14.13 |
| Pretax Margin | 16.00 |
| Profit Margin | 11.82 |
| EBITDA Margin | 14.13 |
Jyothy Labs Limited's most recent stock split took place on June 28, 2018 with a 1:2 split ratio.
| Last Split Date | 6/28/2018 |
| Split Ratio | 1:2 |
Jyothy Labs Limited posts an Altman Z-Score of 16.74, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.74 |